Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-000461-28Phase 4Active
Phase 4, randomised trial of metformin in obesity and cardiac event risk (3 arms), sponsored by Karolinska Institutet. Primary endpoint: Nocturnal blood pressure dipping after 12 months. Started Mar 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-000461-28.